What is Bright Minds Biosciences Inc (DRUG) stock price today?

Bright Minds Biosciences Inc (DRUG) currently trades at $89.11 per share. The stock has a market capitalization of $872.62M and a P/E ratio of —x.

Is DRUG stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Bright Minds Biosciences Inc has a Smart Value Score of 22/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

DRUG

Bright Minds Biosciences Inc

NASDAQ: DRUG · HEALTHCARE · BIOTECHNOLOGY

$89.11

+0.13% today

Updated 2026-04-29

Market cap

$872.62M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-2.02

Dividend yield

—

52W range

$23 – $124

Volume

0.2M

Market cap

$872.62M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-2.02

Dividend yield

—

52W range

$23 – $124

Volume

0.2M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$161.98

+81.78%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy5 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-5.82M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-14.96M	$-7.37M	$-2.80M	$-12.23M	$-7.57M
EPS	—	—	—	—	$-2.02
Free cash flow	$-13.59M	$-7.02M	$-1.85M	$-8.69M	$-5.82M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
DRUG	$872.62M	22	4.3	3.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Bright Minds Biosciences Inc trades at $89.11. Our Smart Value Score of 22/100 indicates the stock is weak.

Frequently asked questions

What is Bright Minds Biosciences Inc's stock price?

Bright Minds Biosciences Inc (DRUG) trades at $89.11.

Is Bright Minds Biosciences Inc overvalued?

Smart Value Score 22/100 (Grade F, Strong Sell).

What is the price target of Bright Minds Biosciences Inc (DRUG)?

The analyst target price is $161.98, representing +81.8% upside from the current price of $89.11.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-27.00%

Beta-0.11

50D MA$80.09

200D MA$64.72

Shares out0.01B

Float0.01B

Short ratio—

Avg volume0.2M

Performance

1 week+0.35%

1 month+21.95%

3 months+7.89%

YTD+14.03%

1 year—

3 years—

5 years—

Compare

DRUG vs LLY →DRUG vs JNJ →DRUG vs ABBV →Stock screener →